The concept of innovative drugs has rebounded after a period of volatility

On July 18th, the concept of innovative drugs experienced a volatile rebound. As of 13:52, Anglikang reached its daily trading limit, with its stock price hitting a new historical high. Hanshang Group saw its stock price increase by 10% for two consecutive days, while Jincheng Pharmaceutical, Oulin Biotech, and Jiankai Technology all rose by over 10%.